AbCellera Biologics (ABCL) Insider Trading & Ownership $1.98 -0.01 (-0.25%) As of 12:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AbCellera Biologics (NASDAQ:ABCL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.90%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$5.17 MNumber OfInsiders Selling(Last 3 Years)0 Get ABCL Insider Trade Alerts Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABCL Insider Buying and Selling by Quarter AbCellera Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/26/2023Andrew BoothCFOBuy14,500$6.85$99,325.00 5/26/2023Holdings Ltd. ThermopylaeMajor ShareholderBuy153,000$6.52$997,560.00 12/16/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy85,102$10.10$859,530.20 8/19/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy200,000$11.46$2,292,000.00 6/13/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy54,915$8.03$440,967.45 6/6/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy64,545$7.50$484,087.50 (Data available from 1/1/2013 forward) ABCL Insider Trading Activity - Frequently Asked Questions Who is on AbCellera Biologics's Insider Roster? The list of insiders at AbCellera Biologics includes Andrew Booth, and Holdings Ltd. Thermopylae. Learn more on insiders at ABCL. What percentage of AbCellera Biologics stock is owned by insiders? 28.90% of AbCellera Biologics stock is owned by insiders. Learn more on ABCL's insider holdings. Which AbCellera Biologics insiders have been buying company stock? The following insiders have purchased ABCL shares in the last 24 months: Andrew Booth ($99,325.00), and Holdings Ltd. Thermopylae ($997,560.00). How much insider buying is happening at AbCellera Biologics? Insiders have purchased a total of 167,500 ABCL shares in the last 24 months for a total of $1,096,885.00 bought. AbCellera Biologics Key ExecutivesDr. Carl L.G. Hansen Ph.D. (Age 49)CEO, President & Chairperson Compensation: $714.94kMr. Andrew Booth M.B.A. (Age 50)Chief Financial Officer Compensation: $674.55kDr. Veronique Lecault Ph.D. (Age 39)COO & Director Compensation: $650.59kMr. Tryn T. Stimart Esq. (Age 54)J.D., M.Sc., Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer Compensation: $667.69kMarcie Thiessen CPACGA, Senior Director of Finance & AccountingDr. Ester Falconer Ph.D. (Age 49)Chief Technology Officer Kathleen Reid B.A.Head of Corporate CommunicationsGraham Craig M.Sc.Director of Corporate DevelopmentMr. Murray McCutcheon Ph.D.Senior Vice President of PartneringMr. Neil Aubuchon B.A. (Age 54)M.B.A., Chief Commercial Officer Compensation: $684.81k More Insider Trading Tools from MarketBeat Related Companies AMRX Insider Ownership OGN Insider Ownership MIRM Insider Ownership APLS Insider Ownership DNLI Insider Ownership VCEL Insider Ownership NAMS Insider Ownership KYMR Insider Ownership BHVN Insider Ownership IBRX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:ABCL) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.